Stocks · News reference
BTIG analyst David Larsen initiates coverage on Omada Health (NASDAQ:OMDA) with a Buy rating and announces Price Target of $30.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-market session. The market value of their outstanding shares is at $40.0 billion. The company's, Q2 earnings came
Read original at benzingaJP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.
Read original at benzingaCitizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperform and raises the price target from $27 to $32.
Read original at benzingaBaird analyst Vikram Kesavabhotla maintains Omada Health (NASDAQ:OMDA) with a Neutral and raises the price target from $15 to $25.
Read original at benzinga